# The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

> **NCT00624559** · PHASE4 · COMPLETED · sponsor: **University of Delaware** · enrollment: 12 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** celecoxib (Celebrex)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00624559
- **Lead sponsor:** University of Delaware
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624559, "The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00624559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*